XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - EUR (€)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Loss Abstract        
Research and development expenses € (10,919,595) € (11,180,958) € (25,651,503) € (21,652,881)
General and administrative expenses (3,540,805) (4,346,965) (7,149,359) (8,734,408)
Sales and marketing expenses (276,051) (276,051)
Other income 4,882,908 14,441,541 12,629,096 14,443,135
Other expenses (2,624) (279) (3,190) (844)
Operating Result (9,856,168) (1,086,661) (20,451,007) (15,944,999)
Finance income 1,087,011 82,401 1,543,047 110,362
Finance expenses (5,052) (7,945) (10,580) (32,531)
Foreign exchange result 767,646 1,563,580 (369,664) 2,291,513
Other financial result (195,567) (86,000) 2,241 39,000
Income Taxes
Income (Loss) for the Period € (8,202,130) € 465,376 € (19,285,963) € (13,536,654)
Share Information        
Weighted average number of shares outstanding (in Shares) 56,985,734 44,203,763 50,912,459 44,203,763
Income (Loss) per share (basic) (in Euro per share) € (0.14) € 0.01 € (0.38) € (0.31)
Other comprehensive income (loss) that may be reclassified to profit or loss in subsequent periods:        
Exchange differences on translation of foreign currency € (330) € 4,408,940 € (17,116) € 5,718,815
Total Comprehensive Income (Loss) € (8,202,460) € 4,874,316 € (19,303,079) € (7,817,839)